Biocompatibility of bacterial magnetosomes: Acute toxicity, immunotoxicity and cytotoxicity

References

• Abraham SA, McKenzie C, Masin D, Ng R, Harasym TO, Mayer LD, Bally MB. 2004. In vitro and in vivo characterization of doxorubicin and vincristine coencapsulated within liposomes through use of transition metal ion complexation and pH gradient loading. Clin Cancer Res 10:728–738.
   PubMed Web of Science ®Google Scholar
• Balkwill DL, Maratea D, Blakemore RP. 1980. Ultrastructure of a magnetic spirillum. J Bacteriol 141(3):1399–1408.
   PubMedGoogle Scholar
• Bazylinski DA, Frankel RB. 2004. Magnetosome formation in prokaryotes. Nat Rev Microbiol 2:217–230.
   PubMed Web of Science ®Google Scholar
• Bazylinski DA, Garratt-Reed AR, Frankel B. 1994. Electron-microscopic studies of magnetosomes in magnetotactic bacteria. Microsc Res Techniq 27:389–401.
   PubMed Web of Science ®Google Scholar
• Blakemore RP. 1975. Magnetotactic bacteria. Science 190:377–379.
   PubMed Web of Science ®Google Scholar
• Bliss C. 1935. The calculation of the dose-mortality curve. Ann Appl Biol 22:134–167.
   Google Scholar
• Borchard G, Kreuter J. 1996. The role of serum complement on the organ distribution of intravenously administered poly(methyl methacrylate) nanoparticles: Effects of pre-coating with plasma and with serum complement. Pharm Res 13(7):1055–1058.
   PubMed Web of Science ®Google Scholar
• Bruce RD. 1985. An up-and-down procedure for acute toxicity testing. Fundam Appl Toxicol 5(1):151–157.
   PubMedGoogle Scholar
• Faivre D, Schüler D. 2008. Magnetotactic bacteria and magnetosomes. Chem Rev 108(11):4875–4898.
   PubMedGoogle Scholar
• Grünberg K, Wawer C, Tebo BM, Schüler D. 2001. A large gene cluster encoding several magnetosome proteins is conserved in different species of magnetotactic bacteria. J Appl Environ Microb 67:4573–4582.
   PubMed Web of Science ®Google Scholar
• Grünberg K, Muller EC, Otto A, Reszka R, Linder D, Kube M, Reinhardt R, Schüler D. 2004. Biochemical and proteomic analysis of the magnetosome membrane in Magnetospirillum gryphiswaldense. Appl Environ Microb 70(2):1040–1050.
   PubMedGoogle Scholar
• Häfeli UO, Pauer GJ. 1999. In vitro and in vivo toxicity of magnetic microspheres. J Magn Magn Mater 194:76–82.
   Web of Science ®Google Scholar
• Hoell A, Wiedenmann A, Heyen U, Schüler D. 2004. Nanostructure and field-induced arrangement of magnetosomes studied by SANSPOL. Physica B 350:309–313.
   Web of Science ®Google Scholar
• Hopkin M. 2004. Magnet-making bacteria could target tumours. Nature (doi:10.1038/news040906-11).
   Google Scholar
• Juillerat-Jeanneret L, Schmitt F. 2007. Chemical modification of therapeutic drugs or drug vector systems to achieve targeted therapy: Looking for the grail. Med Res Rev 27(4):574–590.
   PubMedGoogle Scholar
• Kim JA, Lee HJ, Kang HJ, Park TH. 2009. The targeting of endothelial progenitor cells to a specific location within a microfluidic channel using magnetic nanoparticles. Biomed Microdevices 11(1):287–296.
   PubMedGoogle Scholar
• Lang C, Schüler D, Faivre D. 2007. Synthesis of magnetite nanoparticles for bio- and nanotechnology: Genetic engineering and biomimetics of bacterial magnetosomes. Macromol Biosci 7:144–151.
   PubMed Web of Science ®Google Scholar
• Li X, Jiang W, Sun JB, Wang GL, Guan F, Li Y. 2007. Purified and sterilized magnetosomes from Magnetospirillum gryphiswaldense MSR-1 were not toxic to mouse fibroblasts in vitro. Lett Appl Microbiol 45(1):75–81.
   PubMedGoogle Scholar
• Lobenberg R, Araujo L, Von Briesen H, Rodgers E, Kreuter J. 1998. Body distribution of azidothymidine bound to hexy-cyanoacrylate nanoparticles after i.v. injection to rats. J Control Release 50:21–24.
   PubMed Web of Science ®Google Scholar
• Lorke D. 1983. A new approach to practical acute toxicity testing. Arch Toxicol 54:275–287.
   PubMed Web of Science ®Google Scholar
• Matsunaga T, Kamiya S. 1987. Use of magnetic particles isolated from magnetotactic bacteria for enzyme immobilization. Appl Environ Microb 26:328–332.
   Web of Science ®Google Scholar
• Matsunaga T, Suzuki T, Tanaka M, Arakaki A. 2007. Molecular analysis of magnetotactic bacteria and development of functional bacterial magnetic particles for nano-biotechnology. TRENDS Biotechnol 25(4):182–188.
   PubMedGoogle Scholar
• Matsunaga T, Ueki F, Obata K, Tajima H, Tanaka T, Takeyama H, Goda Y, Fujimoto S. 2003. Fully automated immunoassay system of endocrine disrupting chemicals using monoclonal antibodies chemically conjugated to bacterial magnetic particles. Anal Chim Acta 475:75–83.
   Web of Science ®Google Scholar
• Nakamura N, Matsunaga T. 1993. Highly, sensitive detection of allergen using bacterial magnetic particles. Anal Chim Acta 281:585–589.
   Web of Science ®Google Scholar
• Okamura Y, Takeyama H, Matsunaga T. 2000. Two-dimensional analysis of proteins specific to the bacterial magnetic particle membrane from Magnetospirillum sp. strain AMB-1. Appl Biochem Biotech 84(6):441–446.
   PubMedGoogle Scholar
• Ota H, Takeyama H, Nakayama H, Katoh T, Matsunaga T. 2003. SNP detection in transforming growth factor-1 gene using bacterial magnetic particles. Biosens Bioelectron. 18:683–687.
   PubMed Web of Science ®Google Scholar
• Organization for Economic Co-operation and Development (OECD/OCDE). 2008. Test No. 425: Acute oral toxicity: Up-and-down procedure. In OECD guidelines for the testing of chemicals/Section 4: Health effects. pp 1–27.
   Google Scholar
• Sun JB, Duan JH, Dai SL, Ren J, Zhang YD, Tian JS. Li Y. 2007. In vitro and in vivo antitumor effects of doxorubicin loaded with bacterial magnetosomes (DBMs) on H22 cells: The magnetic bio-nanoparticles as drug carriers. Cancer Lett 258:109–117.
   PubMed Web of Science ®Google Scholar
• Sun JB, Duan JH, Dai SL, Ren J, Guo L, Jiang W, Li Y. 2008. Preparation and Anti-tumor efficiency evaluation of doxorubicin-loaded bacterial magnetosomes, the magnetic nanoparticles as drug carriers isolated from Magnetospirillum gryphiswaldense. Biotechnol Bioeng 101(6):1313–1320.
   PubMedGoogle Scholar
• Sun JB, Wang ZL, Duan JH, Ren J, Yang XD, Dai SL, Li Y. 2009. Targeted distribution of bacterial magnetosomes isolated from Magnetospirillum gryphiswaldense MSR-1 in healthy Sprague-Dawley rats. J Nanosci Nanotechnol 9:1881–1885.
   PubMed Web of Science ®Google Scholar
• Takeyama H, Yamazawa A, Nakamura C, Matsunaga T. 1995. Application of bacterial magnetic particles as novel DNA carriers for ballistic transformation of a marine cyanobacterium. Biotechnol Techniq 9(5):355–360.
   Google Scholar
• Vonarbourg A, Passirani C, Saulnier P, Benoit J-P. 2006. Parameters influencing the stealthiness of colloidal drug delivery systems. Biomaterials 27:4356–4373.
   PubMed Web of Science ®Google Scholar
• Wacker R, Ceyhan B, Alhorn P, Schüler D, Lang C, Niemeyer CM. 2007. Magneto immuno-PCR: A novel immunoassay based on biogenic magnetosome nanoparticles. Biochem Bioph Res Co 357:391–396.
   PubMed Web of Science ®Google Scholar
• Wagner V, Dullaart A, Bock AK, Zweck A. 2006. The emerging nanomedicine landscape. Nat Biotechnol 24(10):1211–1217.
   PubMedGoogle Scholar
• Yam I, Reer PJ, Bruce RD. 1991. Comparison of the up and down method and the fixed-dose procedure for acute oral toxicity testing. Food Chem Toxicol 29(4):259–63.
   PubMedGoogle Scholar
• Yoza B, Matsumoto M, Matsunaga T. 2002. DNA extraction using bacterial magnetic particles in the presence of amino silane compound. J Biotechnol 94:217–224.
   PubMed Web of Science ®Google Scholar
• Yoshino T, Kaji C, Nakai M, Saito F, Takeyama H, Matsunaga T. 2008. Novel method for evaluation of chemicals based on ligand-dependent recruitment of GFP labeled coactivator to estrogen receptor displayed on bacterial magnetic particles. Anal Chim Acta 626:71–77.
   PubMedGoogle Scholar
• Yoshino T, Nishimura T, Mori T, Suzuki S, Kambara H, Takeyama H, Matsunaga T. 2009. Nano-sized bacterial magnetic particles displaying pyruvate phosphate dikinase for pyrosequencing. Biotechnol Bioeng 103(1):130–137.
   PubMedGoogle Scholar